特异性免疫治疗对过敏性鼻炎和哮喘的同步控制/远期效果和肺功能的影响  

Effect of specific immunotherapy on synchronous control,long-term effect and lung function of allergic rhinitis and asthma

作　　者：王敏[1] 王俊卿[1] Wang Min;Wang Junqing(Department of Pulmonary and Critical Care Medicine,Jiuquan People's Hospital,Jiuquan,Gansu,735000 China)

机构地区：[1]甘肃省酒泉市人民医院呼吸与危重症医学科,甘肃酒泉735000

出　　处：《中国医学文摘（耳鼻咽喉科学）》2020年第6期543-545,共3页Chinese Medical Digest(Otorhinolaryngology)

摘　　要：目的探讨特异性免疫治疗对过敏性鼻炎和哮喘的同步控制、远期效果和肺功能的影响。方法将过敏性鼻炎-哮喘综合症患者74例随机分组,对照组37例采用常规治疗;在此基础上,观察组37例采用特异性免疫治疗,测定肺功能和各项观察指标,评估远期效果。结果对照组FEV1、FEF50、FEF75低于观察组,有差异(P < 0.05)。对照组VAS评分、DASS评分、NASS评分高于观察组,ACT评分低于观察组,有差异(P < 0.05)。对照组优良率78.38%低于观察组优良率94.59%,有差异(P < 0.05)。结论特异性免疫治疗对过敏性鼻炎和哮喘的同步控制、远期效果显著,可改善肺功能,值得推广。Objective To investigate the effect of specific immunotherapy on the synchronous control,long-term effect and lung function of allergic rhinitis and asthma.Methods 74 patients with allergic rhinitis asthma syndrome were randomly divided into two groups,The control group(37cases)was treated with conventional therapy,while the observation group(37cases)was treated with specific immunotherapy,The lung function and the observation indexes were measured to evaluate the long-term effect.Results FEV1,fef50 andfef75 in the control group were lower than those in the observation group(P<0.05).The VAS score,dass score and NASS score of the control group were higher than those of the observation group,while the c-act score was lower than that of the observation group(P<0.05).The excellent and good rate of the control group was 78.38%,which was lower than that of the observation group(94.59%)(P<0.05).Conclusions Specific immunotherapy can control allergic rhinitis and asthma simultaneously,and has significant long-term effect.It can improve lung function and is worthy of promotion.

关 键 词：特异性免疫治疗 过敏性鼻炎 哮喘 肺功能 

分 类 号：R73[医药卫生—肿瘤]